ATLANTA, GA -- (MARKET WIRE) -- 06/08/2006 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced today that Russell M. Medford, M.D., Ph.D., President and Chief Executive Officer, is scheduled to present a company overview and update at the Needham & Company Fifth Annual Biotechnology and Medical Technology Conference on Wednesday, June 14, 2006, at 4:30 p.m. EDT at The New York Palace Hotel in New York City.
